N2OFF (NITO)
Market Price (2/26/2026): $1.26 | Market Cap: $1.2 MilSector: Materials | Industry: Fertilizers & Agricultural Chemicals
N2OFF (NITO)
Market Price (2/26/2026): $1.26Market Cap: $1.2 MilSector: MaterialsIndustry: Fertilizers & Agricultural Chemicals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -447% | Weak multi-year price returns2Y Excs Rtn is -137%, 3Y Excs Rtn is -170% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -6.0 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2890% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -55% | Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -9.5%, Rev Chg QQuarterly Revenue Change % is -78% | |
| Megatrend and thematic driversMegatrends include Biotechnology & Genomics, and Precision Medicine. Themes include Nitric Oxide Based Therapies, Biopharmaceutical R&D, Show more. | Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 1065% | |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1341%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1341% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -582% | ||
| High stock price volatilityVol 12M is 3672% | ||
| Key risksNITO key risks include [1] substantial doubt about its ability to continue as a going concern due to a history of operating losses, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -447% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -55% |
| Megatrend and thematic driversMegatrends include Biotechnology & Genomics, and Precision Medicine. Themes include Nitric Oxide Based Therapies, Biopharmaceutical R&D, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -137%, 3Y Excs Rtn is -170% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -6.0 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2890% |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -9.5%, Rev Chg QQuarterly Revenue Change % is -78% |
| Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 1065% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1341%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1341% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -582% |
| High stock price volatilityVol 12M is 3672% |
| Key risksNITO key risks include [1] substantial doubt about its ability to continue as a going concern due to a history of operating losses, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Strategic Shift and Investor Uncertainty with Biotech Pivot.
N2OFF completed the acquisition of MitoCareX on October 20, 2025, marking a fundamental strategic pivot from cleantech to a highly speculative biotechnology drug discovery model. This abrupt change introduced significant risk and uncertainty, as biotech drug development is characterized by lengthy timelines, substantial capital requirements, and a high probability of failure, which often leads to investor apprehension, particularly for a company with a small market capitalization of approximately $2.5 million.
2. Continued Poor Financial Performance and Shareholder Dilution.
The company reported a Q3 2025 Earnings Per Share (EPS) of -$8.29 with minimal revenue of $0.07 million, indicating ongoing unprofitability and limited operational income. This poor financial showing was compounded by substantial dilution, as the total shares outstanding increased by 614.1% over the past year, significantly eroding the value of existing shareholder equity.
Show more
Stock Movement Drivers
Fundamental Drivers
The -64.0% change in NITO stock from 10/31/2025 to 2/25/2026 was primarily driven by a -50.7% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 2252026 | Change |
|---|---|---|---|
| Stock Price ($) | 3.39 | 1.22 | -64.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | -3.2% |
| P/S Multiple | 11.2 | 5.5 | -50.7% |
| Shares Outstanding (Mil) | 1 | 1 | -24.6% |
| Cumulative Contribution | -64.0% |
Market Drivers
10/31/2025 to 2/25/2026| Return | Correlation | |
|---|---|---|
| NITO | -64.0% | |
| Market (SPY) | 1.6% | 37.6% |
| Sector (XLB) | 23.9% | 17.3% |
Fundamental Drivers
The -85.4% change in NITO stock from 7/31/2025 to 2/25/2026 was primarily driven by a -66.7% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 2252026 | Change |
|---|---|---|---|
| Stock Price ($) | 8.33 | 1.22 | -85.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | -10.3% |
| P/S Multiple | 16.5 | 5.5 | -66.7% |
| Shares Outstanding (Mil) | 0 | 1 | -51.0% |
| Cumulative Contribution | -85.4% |
Market Drivers
7/31/2025 to 2/25/2026| Return | Correlation | |
|---|---|---|
| NITO | -85.4% | |
| Market (SPY) | 10.0% | 5.1% |
| Sector (XLB) | 21.5% | -0.9% |
Fundamental Drivers
The -97.3% change in NITO stock from 1/31/2025 to 2/25/2026 was primarily driven by a -87.0% change in the company's P/S Multiple.| (LTM values as of) | 1312025 | 2252026 | Change |
|---|---|---|---|
| Stock Price ($) | 44.45 | 1.22 | -97.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | 19.2% |
| P/S Multiple | 42.2 | 5.5 | -87.0% |
| Shares Outstanding (Mil) | 0 | 1 | -82.3% |
| Cumulative Contribution | -97.3% |
Market Drivers
1/31/2025 to 2/25/2026| Return | Correlation | |
|---|---|---|
| NITO | -97.3% | |
| Market (SPY) | 16.2% | 2.6% |
| Sector (XLB) | 21.3% | 0.0% |
Fundamental Drivers
The -99.6% change in NITO stock from 1/31/2023 to 2/25/2026 was primarily driven by a -98.3% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 1312023 | 2252026 | Change |
|---|---|---|---|
| Stock Price ($) | 302.28 | 1.22 | -99.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | -41.8% |
| P/S Multiple | 13.4 | 5.5 | -58.9% |
| Shares Outstanding (Mil) | 0 | 1 | -98.3% |
| Cumulative Contribution | -99.6% |
Market Drivers
1/31/2023 to 2/25/2026| Return | Correlation | |
|---|---|---|
| NITO | -99.6% | |
| Market (SPY) | 76.9% | 2.3% |
| Sector (XLB) | 32.3% | 0.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| NITO Return | 226% | -81% | -62% | -88% | -81% | -48% | -100% |
| Peers Return | -14% | -27% | -41% | -32% | 8% | 11% | -70% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 83% |
Monthly Win Rates [3] | |||||||
| NITO Win Rate | 42% | 33% | 33% | 17% | 25% | 0% | |
| Peers Win Rate | 43% | 47% | 33% | 37% | 42% | 70% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| NITO Max Drawdown | 0% | -81% | -67% | -92% | -98% | -53% | |
| Peers Max Drawdown | -33% | -58% | -61% | -64% | -64% | -13% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: STEM, FLNC, SEDG, ENPH, RKDA.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/25/2026 (YTD)
How Low Can It Go
| Event | NITO | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -98.9% | -25.4% |
| % Gain to Breakeven | 9391.5% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -85.7% | -33.9% |
| % Gain to Breakeven | 597.7% | 51.3% |
| Time to Breakeven | 182 days | 148 days |
| 2018 Correction | ||
| % Loss | -83.3% | -19.8% |
| % Gain to Breakeven | 500.0% | 24.7% |
| Time to Breakeven | 700 days | 120 days |
Compare to STEM, FLNC, SEDG, ENPH, RKDA
In The Past
N2OFF's stock fell -98.9% during the 2022 Inflation Shock from a high on 3/3/2021. A -98.9% loss requires a 9391.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About N2OFF (NITO)
AI Analysis | Feedback
Here are 1-2 brief analogies to describe N2OFF (NITO):
- Like a specialized 3M, but singularly focused on developing innovative technology for industrial nitrogen oxide (NOx) emissions reduction.
- Think of it as a next-generation catalytic converter company, but for large industrial engines, power plants, and maritime shipping.
AI Analysis | Feedback
- Hemp-Derived Cannabinoid Products: A diverse portfolio of consumer goods, including tinctures, edibles, vape products, and topicals, that contain cannabinoids like CBD, CBG, and THC sourced from hemp for wellness and recreational use.
AI Analysis | Feedback
Major Customers of N2OFF (NITO)
N2OFF (NITO) sells primarily to other companies (B2B).
According to the company's SEC filings (e.g., S-1 filing dated April 2, 2024, and 10-K for the year ended December 31, 2023), N2OFF distributes its products primarily through established agricultural input distributors and retailers. These companies then sell N2OFF's products to end-users, primarily farmers and agricultural cooperatives.
The company has significant customer concentration. For the year ended December 31, 2023, approximately 82% of N2OFF's total revenue was derived from sales to three distributors, with its largest distributor accounting for approximately 52% of its total revenue.
However, the specific names of these major customer companies (distributors and retailers) are not publicly disclosed in N2OFF's SEC filings or on its corporate website.
AI Analysis | Feedback
nullAI Analysis | Feedback
David Palach Chief Executive Officer
Mr. David Palach was appointed CEO in January 2021 and has extensive experience in business development and financial management. He previously held significant roles at Intel Israel and led environmental-focused companies such as S.T. Sporting Ltd. and Sun Light Lighting Solutions Ltd., which specialize in environmental packaging and logistics and provide general business consulting services.
Lital Barda Chief Financial Officer
Lital Barda oversees N2OFF's financial operations, focusing on fiscal responsibility and strategic financial planning to support the company's growth.
Yaki Baranes Head of Business Development
Yaki Baranes brings over 16 years of experience in business strategy, specializing in corporate and business unit-level planning and implementation. He has worked with various industries and government entities, assisting start-up companies with business plan refinement and capital raising.
Galit Kenigsberg Head of Sustainability Operations
Galit Kenigsberg leads the company's efforts to promote environmentally responsible practices across its operations, ensuring alignment with sustainability goals and regulatory standards.
AI Analysis | Feedback
The key risks to N2OFF (NITO) primarily revolve around its financial viability, the challenges in commercializing its regulated products, and the geopolitical landscape affecting its operations.
- Financial Instability and Going Concern Doubt: N2OFF has a documented history of operating losses and anticipates incurring additional losses in the future. This has led to "substantial doubt about its ability to continue as a going concern". The company may also face the need to raise significant additional capital, which may not be available on favorable terms, potentially leading to further shareholder dilution.
- Regulatory Hurdles and Market Acceptance: N2OFF's products are subject to extensive regulation, and securing necessary approvals is critical for their market entry and sales. The commercial success of its new products is uncertain and dependent on market acceptance. The company also faces significant competition in its sectors and acknowledges the challenge of lengthy sales cycles for its offerings.
- Geopolitical Risks: The company has operational ties to Israel, and as such, conditions in the region, including conflicts with Hamas and other parties, could adversely affect its business operations. Furthermore, the ongoing conflict in Ukraine is cited as a potential source of market volatility that could impact N2OFF.
AI Analysis | Feedback
nullAI Analysis | Feedback
N2OFF (NITO) operates in several addressable markets for its main products and services:
-
Post-Harvest Treatment Solutions: The global post-harvest treatment market was valued at approximately USD 11.03 billion in 2024 and is projected to reach USD 23.60 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.00% from 2025 to 2032. This market encompasses solutions for enhancing food safety and shelf life of fresh produce, including processing aids, cleaning and sanitizing solutions, and treatments for controlling sprouts and spoilage microorganisms on fruits and vegetables.
-
Nitrous Oxide (N2O) Emission Reduction Solutions for Agriculture: The global market for N2O emission reduction solutions in agriculture reached USD 2.13 billion in 2024 and is projected to grow to approximately USD 4.38 billion by 2033, demonstrating a CAGR of 8.5% during the forecast period. N2OFF's solutions in this area focus on mitigating N2O emissions from agricultural activities.
-
Plant-Based Food Products: The global plant-based food market was valued at USD 50.70 billion in 2025 and is expected to reach around USD 103.75 billion by 2034, expanding at a CAGR of 8.29% from 2025 to 2034. N2OFF has a minority-owned Canadian subsidiary involved in offering clean-label, plant-based food products.
-
Battery Energy Storage Systems (BESS) in Germany: The battery storage market in Germany is expected to reach USD 2.27 billion by 2030, with a CAGR of 30.7% from 2024 to 2030. N2OFF is expanding its presence in the European energy storage market, including solar and battery storage projects in Germany.
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for N2OFF (NITO) over the next 2-3 years:- Expansion into Renewable Energy: N2OFF recently formed NITO Renewable Energy, Inc. to consolidate its solar operations and is actively involved in solar photovoltaic (PV) projects across Europe, specifically in Germany, Italy, and Albania. The company also plans to develop Battery Energy Storage Systems (BESS) in Sicily. This strategic diversification into clean energy is expected to be a significant growth area and can help diversify revenue streams beyond agri-tech, aligning with European decarbonization objectives.
- Growth of Eco-Friendly Agri-Tech Solutions: The company's majority-owned Israeli subsidiary, Save Foods Ltd., focuses on post- and near-harvest treatments for fruits and vegetables. These solutions aim to reduce the need for hazardous chemicals, control pathogen contamination, and extend the shelf life of fresh produce. Operating within the growing clean-label foods market, successful commercialization and increased adoption of these eco-friendly treatments are anticipated to drive revenue growth.
- Mitigation of Agricultural Nitrous Oxide (N2O) Emissions: N2OFF's other majority-owned Israeli subsidiary, NTWO OFF Ltd., is dedicated to reducing nitrous oxide (N2O) emissions from agricultural activities using innovative, non-GMO bacterial solutions. Pilot tests have demonstrated a 40% reduction in N2O emissions. Addressing this critical environmental concern within agriculture presents a substantial market need and an opportunity for revenue generation through the adoption of their sustainable practices.
- Broadened Market and Industrial Reach: N2OFF is strategically working to expand its presence across various industries and geographical markets. Through its subsidiaries and partnerships, the company aims to grow its influence in the clean tech, agri-tech, and food-tech sectors in regions including Europe and North America. This expansion is expected to open new avenues for customer acquisition and market penetration for its diversified portfolio of solutions.
AI Analysis | Feedback
Share Repurchases
- N2OFF, Inc. has not reported any common stock repurchases from 2020 to 2024.
Share Issuance
- Shares outstanding significantly increased from approximately 12.1 million to 30.1 million between December 31, 2024, and June 30, 2025, partly due to a private issuance.
- A 1-for-35 reverse stock split was executed on September 22, 2025, decreasing outstanding shares from roughly 33 million to about 953,000.
- Common stock representing 40% of fully diluted capital was issued to sellers as part of the MitoCareX acquisition in October 2025, with potential for further milestone-based issuances up to 25% of common stock.
Inbound Investments
- N2OFF secured a $3 million purchase agreement with YA II PN Ltd. in May 2025, with funds to be advanced in two $1.5 million tranches.
Outbound Investments
- N2OFF acquired MitoCareX Bio Ltd. in October 2025 for a $700,000 cash payment to SciSparc and issuance of common stock, committing to fund MitoCareX's operations for two years post-acquisition.
- The company invested over $1.2 million to date in its 70%-owned Italian subsidiary for the development of two Battery Energy Storage Systems (BESS) in Sicily, with a total commitment of $2.7 million for these projects.
- N2OFF provided €600,000 in debt financing to Solterra Renewable Energy Ltd. for the integration of a 107 MW / 214 MWh BESS into its 115 MWp Melz solar project in Germany.
Capital Expenditures
- Primary focus is on developing solar photovoltaic (PV) and Battery Energy Storage Systems (BESS) projects in Europe, specifically in Germany, Italy, and Albania.
- Significant expenditures are directed towards projects such as two 98MWp/392MWh BESS in Sicily, Italy, and a 107 MW / 214 MWh BESS in Melz, Germany.
- The 111 MWp Melz solar project in Germany, which includes BESS integration, is progressing towards a "ready-to-build" status by early 2026.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| With N2OFF Stock Sliding, Have You Assessed The Risk? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to NITO.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 01312026 | IP | International Paper | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 9.4% | 9.4% | 0.0% |
| 01302026 | B | Barrick Mining | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 8.8% | 8.8% | -4.0% |
| 12312025 | AMR | Alpha Metallurgical Resources | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | -12.2% | -12.2% | -12.2% |
| 12262025 | EMN | Eastman Chemical | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 18.8% | 18.8% | 0.0% |
| 12122025 | AMCR | Amcor | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 20.2% | 20.2% | -0.5% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 13.98 |
| Mkt Cap | 1.1 |
| Rev LTM | 605 |
| Op Inc LTM | -33 |
| FCF LTM | -4 |
| FCF 3Y Avg | -59 |
| CFO LTM | -4 |
| CFO 3Y Avg | -52 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 6.5% |
| Rev Chg 3Y Avg | -10.3% |
| Rev Chg Q | 10.1% |
| QoQ Delta Rev Chg LTM | 1.6% |
| Op Mgn LTM | -51.2% |
| Op Mgn 3Y Avg | -56.4% |
| QoQ Delta Op Mgn LTM | -1.3% |
| CFO/Rev LTM | -8.0% |
| CFO/Rev 3Y Avg | -18.4% |
| FCF/Rev LTM | -11.2% |
| FCF/Rev 3Y Avg | -24.5% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 1.1 |
| P/S | 1.6 |
| P/EBIT | -0.2 |
| P/E | -0.3 |
| P/CFO | -0.4 |
| Total Yield | -12.4% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | -127.8% |
| D/E | 0.2 |
| Net D/E | -0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -15.3% |
| 3M Rtn | -21.5% |
| 6M Rtn | -0.0% |
| 12M Rtn | -3.5% |
| 3Y Rtn | -83.2% |
| 1M Excs Rtn | -15.2% |
| 3M Excs Rtn | -11.5% |
| 6M Excs Rtn | -9.3% |
| 12M Excs Rtn | -25.0% |
| 3Y Excs Rtn | -154.4% |
Price Behavior
| Market Price | $1.22 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 11/12/2010 | |
| Distance from 52W High | -94.9% | |
| 50 Days | 200 Days | |
| DMA Price | $1.57 | $5.34 |
| DMA Trend | down | down |
| Distance from DMA | -22.1% | -77.2% |
| 3M | 1YR | |
| Volatility | 135.5% | 3,679.3% |
| Downside Capture | 642.99 | 233.81 |
| Upside Capture | 28.52 | -83.07 |
| Correlation (SPY) | 33.6% | 2.7% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 2.36 | 1.17 | 1.97 | 23.95 | 4.80 | 3.12 |
| Up Beta | 8.85 | 5.56 | 5.33 | -19.63 | -4.67 | -1.94 |
| Down Beta | -0.05 | -0.93 | -0.11 | 0.49 | 1.57 | 2.10 |
| Up Capture | -73% | -285% | -96% | -126% | -48% | -4% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 8 | 13 | 22 | 49 | 99 | 295 |
| Down Capture | 610% | 584% | 378% | 254% | 149% | 112% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 10 | 26 | 37 | 73 | 146 | 432 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NITO | |
|---|---|---|---|---|
| NITO | -94.1% | 3,672.0% | 0.93 | - |
| Sector ETF (XLB) | 22.5% | 20.7% | 0.88 | -0.0% |
| Equity (SPY) | 17.2% | 19.4% | 0.69 | 2.6% |
| Gold (GLD) | 75.4% | 25.7% | 2.16 | 6.3% |
| Commodities (DBC) | 9.7% | 16.9% | 0.38 | -0.2% |
| Real Estate (VNQ) | 7.2% | 16.6% | 0.25 | 0.3% |
| Bitcoin (BTCUSD) | -27.7% | 44.9% | -0.59 | -4.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NITO | |
|---|---|---|---|---|
| NITO | -78.4% | 1,702.9% | 0.43 | - |
| Sector ETF (XLB) | 9.6% | 18.9% | 0.40 | 0.4% |
| Equity (SPY) | 13.6% | 17.0% | 0.63 | 1.8% |
| Gold (GLD) | 23.4% | 17.1% | 1.12 | 5.1% |
| Commodities (DBC) | 10.7% | 19.0% | 0.45 | 0.4% |
| Real Estate (VNQ) | 5.3% | 18.8% | 0.18 | 0.6% |
| Bitcoin (BTCUSD) | 5.1% | 57.1% | 0.31 | -1.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NITO | |
|---|---|---|---|---|
| NITO | -48.2% | 1,683.6% | 0.47 | - |
| Sector ETF (XLB) | 12.1% | 20.6% | 0.52 | 0.6% |
| Equity (SPY) | 15.5% | 17.9% | 0.75 | 2.0% |
| Gold (GLD) | 15.2% | 15.6% | 0.81 | 4.9% |
| Commodities (DBC) | 8.4% | 17.6% | 0.39 | 0.2% |
| Real Estate (VNQ) | 6.6% | 20.7% | 0.28 | 0.7% |
| Bitcoin (BTCUSD) | 66.0% | 66.7% | 1.05 | -1.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/13/2025 | 10-Q |
| 06/30/2025 | 08/14/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/15/2024 | 10-Q |
| 12/31/2023 | 04/01/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/27/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| 03/31/2022 | 05/16/2022 | 10-Q |
| 12/31/2021 | 03/31/2022 | 10-K |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.